top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjournal

Abstract Aims Pexelizumab, a monoclonal antibody inhibiting C5, reduced 90 day mortality and shock in the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial without ...

European Heart Journal, Théroux, Pierre, Armstrong, Paul W., Mahaffey, Kenneth W., Hochman, Judith S., Malloy, Kevin J., Rollins, Scott, Nicolau, Jose C., Lavoie, Joel, Luong, The Minh, Burchenal, ...

Date : 01/10/2005
Ehjournal

[...]in nondiabetic patients (n=1219), higher baseline glucose predicted higher mortality [hazard ratio (HR) 1.12, 95% confidence interval (CI) 1.041.20, per 0.6mmol/L increase], and a greater 24h ...

European Heart Journal, Goyal, Abhinav, Mahaffey, Kenneth W., Garg, Jyotsna, Nicolau, Jose C., Hochman, Judith S., Weaver, W. Douglas, Theroux, Pierre, Oliveira, Gustavo B.F., Todaro, Thomas G., ...

Date : 01/06/2006
Ehjournal

In addition to its pro-inflammatory effects, glucose may also directly contribute to the pathogenesis of AMI by promoting thrombosis2 and impairing vasoreactivity.3 We and others4,5 concur that the ...

European Heart Journal, Goyal, Abhinav, Mahaffey, Kenneth W., Garg, Jyotsna, Nicolau, Jose C., Hochman, Judith S., Weaver, W. Douglas, Oliveira, Gustavo B.F., Todaro, Thomas T., Granger, Christopher ...

Date : 01/09/2006
Ehjournal

Abstract Aims Pexelizumab, a monoclonal antibody inhibiting C5, reduced 90 day mortality and shock in the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial without ...

European Heart Journal, Théroux, Pierre, Armstrong, Paul W., Mahaffey, Kenneth W., Hochman, Judith S., Malloy, Kevin J., Rollins, Scott, Nicolau, Jose C., Lavoie, Joel, Luong, The Minh, Burchenal, ...

Date : 01/10/2005 Item size : 173396 bytes
Ehjournal

Methods and results In 6066 STEMI patients enrolled in the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial with complete electrocardiographic data, we assessed the ...

European Heart Journal, Chang, Wei-Ching, Kaul, Padma, Fu, Yuling, Westerhout, Cynthia M., Granger, Christopher B., Mahaffey, Kenneth W., Wallentin, Lars, Van de Werf, Frans, Armstrong, Paul W.

Date : 01/02/2006 Item size : 180042 bytes
Ehjournal

The current ESC and ACC/AHA guidelines advocate greater than 50% resolution of ST-segment elevation at 6090 min following fibrinolysis as a marker of successful reperfusion.1,2 This metric is also ...

European Heart Journal, Tjandrawidjaja, Michael C., Fu, Yuling, Westerhout, Cynthia M., White, Harvey D., Todaro, Thomas G., Van de Werf, Frans, Mahaffey, Kenneth W., Wagner, Galen S., Granger, ...

Date : 01/03/2010 Item size : 301978 bytes
Ehjournal

Abstract Aims Pexelizumab, a monoclonal antibody inhibiting C5, reduced 90 day mortality and shock in the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial without ...

European Heart Journal, Théroux, Pierre, Armstrong, Paul W., Mahaffey, Kenneth W., Hochman, Judith S., Malloy, Kevin J., Rollins, Scott, Nicolau, Jose C., Lavoie, Joel, Luong, The Minh, Burchenal, ...

Date : 01/10/2005
Ehjournal

Citation Abhinav Goyal, Kenneth W. Mahaffey, Jyotsna Garg, Jose C. Nicolau, Judith S. Hochman, W. Douglas Weaver, Gustavo B.F. Oliveira, Thomas T. Todaro, Christopher B. Granger; Glucose, insulin, ...

European Heart Journal, Goyal, Abhinav, Mahaffey, Kenneth W., Garg, Jyotsna, Nicolau, Jose C., Hochman, Judith S., Weaver, W. Douglas, Oliveira, Gustavo B.F., Todaro, Thomas T., Granger, Christopher ...

Date : 01/09/2006 Item size : 115696 bytes
Ehjournal

Methods and results In 6066 STEMI patients enrolled in the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial with complete electrocardiographic data, we assessed the ...

European Heart Journal, Chang, Wei-Ching, Kaul, Padma, Fu, Yuling, Westerhout, Cynthia M., Granger, Christopher B., Mahaffey, Kenneth W., Wallentin, Lars, Van de Werf, Frans, Armstrong, Paul W.

Date : 01/02/2006 Item size : 191570 bytes
Ehjournal

[...]in nondiabetic patients (n=1219), higher baseline glucose predicted higher mortality [hazard ratio (HR) 1.12, 95% confidence interval (CI) 1.041.20, per 0.6mmol/L increase], and a greater 24h ...

European Heart Journal, Goyal, Abhinav, Mahaffey, Kenneth W., Garg, Jyotsna, Nicolau, Jose C., Hochman, Judith S., Weaver, W. Douglas, Theroux, Pierre, Oliveira, Gustavo B.F., Todaro, Thomas G., ...

Date : 01/06/2006 Item size : 320129 bytes